المؤلفون: Hershman DL; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA. dlh23@columbia.edu., Chen BE; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada., Sathe C; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA., Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada., Lemieux J; CHU de Québec-Université Laval, Québec, QC, Canada., Ligibel JA; Dana-Farber Cancer Institute, Boston, MA, USA., Gelmon KA; BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada., Whelan TJ; Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada., Goodwin PJ; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Jul; Vol. 200 (1), pp. 93-102. Date of Electronic Publication: 2023 May 09.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology , Metformin*/adverse effects, Humans ; Female ; Disease-Free Survival ; Double-Blind Method ; Progression-Free Survival

المؤلفون: Lohmann AE; Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada.; Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada., Liebman MF; Children's Hospital of Eastern Ontario, Ottawa, ON, Canada., Brien W; University Health Network, University of Toronto, Toronto, ON, Canada., Parulekar WR; Canadian Cancer Trials Group (CCTG), Cancer Research Institute, Queen's University, Kingston, ON, Canada., Gelmon KA; British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada., Shepherd LE; Canadian Cancer Trials Group (CCTG), Cancer Research Institute, Queen's University, Kingston, ON, Canada., Ligibel JA; Dana-Farber Cancer Institute, Boston, MA, USA., Hershman DL; Columbia University Medical Center, New York, NY, USA., Rastogi P; National Surgical Adjuvant Breast and Bowel Project and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA., Mayer IA; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Hobday TJ; Mayo Clinic College of Medicine, Rochester, MN, USA., Lemieux J; Centre Hospitalier Universitaire de Québec, Quebec, QC, Canada., Thompson AM; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pritchard KI; Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, ON, Canada., Whelan TJ; Juravinski Cancer Centre, Hamilton, ON, Canada., Mukherjee SD; Juravinski Cancer Centre, Hamilton, ON, Canada., Chalchal HI; Allan Blair Cancer Center, Regina, SK, Canada., Bernstein V; British Columbia Cancer Agency, Vancouver Island Center, University of British Columbia, Vancouver, BC, Canada., Stambolic V; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada., Chen BE; Canadian Cancer Trials Group (CCTG), Cancer Research Institute, Queen's University, Kingston, ON, Canada., Goodwin PJ; Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada. pamela.goodwin@sinaihealthsystem.ca.; Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada. pamela.goodwin@sinaihealthsystem.ca.

مؤلفون مشاركون: From the CCTG, Alliance, SWOG, ECOG, NSABP Cooperative Groups

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2017 Jul; Vol. 164 (2), pp. 371-378. Date of Electronic Publication: 2017 Apr 26.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , Breast Neoplasms/*drug therapy , Metformin/*administration & dosage , Vitamin B 12/*blood, Adult ; Antineoplastic Agents/therapeutic use ; Breast Neoplasms/blood ; Breast Neoplasms/metabolism ; Female ; Homocysteine/blood ; Humans ; Metformin/therapeutic use ; Methylmalonic Acid/blood ; Middle Aged ; Treatment Outcome

المؤلفون: Lin NU; Harvard Medical School, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA, nlin@partners.org., Freedman RA, Ramakrishna N, Younger J, Storniolo AM, Bellon JR, Come SE, Gelman RS, Harris GJ, Henderson MA, Macdonald SM, Mahadevan A, Eisenberg E, Ligibel JA, Mayer EL, Moy B, Eichler AF, Winer EP

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2013 Nov; Vol. 142 (2), pp. 405-14. Date of Electronic Publication: 2013 Nov 07.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Brain Neoplasms/*radiotherapy , Brain Neoplasms/*secondary , Breast Neoplasms/*drug therapy , Breast Neoplasms/*pathology , Quinazolines/*therapeutic use , Receptor, ErbB-2/*metabolism, Adult ; Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Brain Neoplasms/drug therapy ; Brain Neoplasms/metabolism ; Breast Neoplasms/radiotherapy ; Female ; Humans ; Lapatinib ; Middle Aged ; Quality of Life ; Quinazolines/administration & dosage ; Quinazolines/adverse effects ; Trastuzumab ; Treatment Outcome

المؤلفون: Ligibel JA; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. jligibel@partners.org, O'Malley AJ, Fisher M, Daniel GW, Winer EP, Keating NL

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2012 Aug; Vol. 134 (3), pp. 1305-13. Date of Electronic Publication: 2012 Jul 12.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Aromatase Inhibitors/*adverse effects , Bone Density/*drug effects , Breast Neoplasms/*epidemiology, Aged ; Aged, 80 and over ; Aromatase Inhibitors/therapeutic use ; Breast Neoplasms/drug therapy ; Cohort Studies ; Comorbidity ; Female ; Humans ; Middle Aged ; Time Factors

المؤلفون: Ligibel JA; Dana-Farber Cancer Institute, 450 Brookline Ave Boston, Boston, MA 02215, USA. jligibel@partners.org, Meyerhardt J, Pierce JP, Najita J, Shockro L, Campbell N, Newman VA, Barbier L, Hacker E, Wood M, Marshall J, Paskett E, Shapiro C

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2012 Feb; Vol. 132 (1), pp. 205-13. Date of Electronic Publication: 2011 Nov 24.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Exercise* , Physical Fitness* , Survivors* , Telephone*, Breast Neoplasms/*therapy , Colorectal Neoplasms/*therapy , Exercise Therapy/*methods, Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Motivation ; Quality of Life ; Surveys and Questionnaires ; Treatment Outcome

المؤلفون: Ligibel JA; Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., James O'Malley A, Fisher M, Daniel GW, Winer EP, Keating NL

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2012 Jan; Vol. 131 (2), pp. 589-97. Date of Electronic Publication: 2011 Sep 01.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*complications , Fractures, Bone/*epidemiology , Myocardial Infarction/*epidemiology , Stroke/*epidemiology, Aged ; Aged, 80 and over ; Antineoplastic Agents, Hormonal/adverse effects ; Antineoplastic Agents, Hormonal/therapeutic use ; Aromatase Inhibitors/adverse effects ; Aromatase Inhibitors/therapeutic use ; Breast Neoplasms/drug therapy ; Cohort Studies ; Female ; Fractures, Bone/chemically induced ; Humans ; Incidence ; Middle Aged ; Myocardial Infarction/chemically induced ; Risk ; Stroke/chemically induced ; Tamoxifen/adverse effects ; Tamoxifen/therapeutic use

المؤلفون: Goodwin PJ; Department of Medicine, Division of Clinical Epidemiology at the Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. pgoodwin@mtsinai.on.ca, Stambolic V, Lemieux J, Chen BE, Parulekar WR, Gelmon KA, Hershman DL, Hobday TJ, Ligibel JA, Mayer IA, Pritchard KI, Whelan TJ, Rastogi P, Shepherd LE

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2011 Feb; Vol. 126 (1), pp. 215-20. Date of Electronic Publication: 2010 Oct 26.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Breast Neoplasms/*drug therapy , Hypoglycemic Agents/*therapeutic use , Metformin/*therapeutic use, Breast Neoplasms/pathology ; Clinical Trials, Phase III as Topic ; Diabetes Mellitus, Type 2/drug therapy ; Evaluation Studies as Topic ; Female ; Humans ; Prognosis